Paris
France
11
2018-01-25
9
2019-11-19
These are the the leading inventors for applications assigned to HYBRIGENICS SA:
HYBRIGENICS SA based in Paris, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Combinations of inecalcitol with an anti-CD38 agent and their uses for treating cancer
#2 | 2015-03-12 ✅ Patent 9,328,093 granted on 2016-05-03Selective inhibitors of ubiquitin specific protease 7, the pharmaceutical compositions thereof and their therapeutic applications
#3 | 2014-12-18 ✅ Patent 9,546,150 granted on 2017-01-17Substituted quinazolin-4-ones for inhibiting ubiquitin specific protease 7
#4 | 2013-01-24NOVEL SELECTIVE INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 7, THE PHARMACEUTICAL COMPOSITIONS THEREOF AND THEIR THERAPEUTIC APPLICATIONS
#5 | 2012-01-19FORMULATIONS OF 14-EPI-ANALOGUES OF VITAMIN D
#6 | 2012-01-19 ✅ Patent 9,314,474 granted on 2016-04-19Formulations of 14-epi-analogues of vitamin D
#7 | 2011-07-28 ✅ Patent 9,315,455 granted on 2016-04-19Process for isomerizing fused bicyclic structures and preparation of vitamin D analogs comprising the same
#8 | 2011-01-20 ✅ Patent 8,481,514 granted on 2013-07-09Therapeutical uses of inecalcitol
#9 | 2009-08-27 ✅ Patent 8,648,076 granted on 2014-02-11Cysteine protease inhibitors and their therapeutic applications
#10 | 2008-05-01 ✅ Patent 7,875,613 granted on 2011-01-25Tetracyclic inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications
#11 | 2007-06-14 ✅ Patent 7,462,615 granted on 2008-12-09Inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications
Also check out HYBRIGENICS SA's (Paris, France) applicant profile with 2 patent applications submitted.
6102 ⎘